Anhedonia difference between major depressive disorder and bipolar disorder II

Area of Science:

• Psychiatry
• Clinical Psychology
• Neuroscience

Background:

• Anhedonia, the diminished ability to experience pleasure, is a core symptom in mood disorders.
• Differentiating Major Depressive Disorder (MDD) from Bipolar II Disorder (BD-II) is clinically significant for appropriate treatment.
• The role of anhedonia in distinguishing MDD from BD-II requires further investigation.

Purpose of the Study:

• To compare the severity of anhedonia between patients diagnosed with MDD and BD-II.
• To evaluate the utility of the Snaith-Hamilton Pleasure Scale (SHAPS) in differentiating between MDD and BD-II.
• To identify clinical factors that may aid in distinguishing BD-II from MDD.

Main Methods:

• A cohort of 164 drug-free patients (98 with MDD, 66 with BD-II) were assessed.
• Participants completed the 17-item Hamilton Depression Scale (HAMD-17), Hamilton Anxiety Scale (HAMA), and SHAPS.
• Statistical analyses included stepwise logistic regression and Receiver Operating Characteristic (ROC) curve analysis.

Main Results:

• Patients with BD-II reported significantly higher SHAPS scores, indicating more severe anhedonia, compared to MDD patients.
• SHAPS score, drinking habits, and extroversion emerged as significant predictors for identifying BD-II.
• ROC analysis demonstrated SHAPS' ability to differentiate BD-II from MDD (AUC=0.655), with optimal cutoff at 26 (sensitivity=0.788, specificity=0.520).

Conclusions:

• BD-II is associated with more pronounced anhedonia than MDD.
• Anhedonia, as measured by SHAPS, shows potential as a preliminary diagnostic marker to distinguish BD-II from MDD.
• Further research is warranted to validate these findings and explore their clinical implications.